"10.1371_journal.pone.0039790","plos one","2012-06-27T00:00:00Z","Jonathan E Feig; Yuliya Vengrenyuk; Vladimir Reiser; Chaowei Wu; Alexander Statnikov; Constantin F Aliferis; Michael J Garabedian; Edward A Fisher; Oscar Puig","Division of Cardiology, and the Marc and Ruti Bell Program in Vascular Biology, Department of Medicine, New York University School of Medicine, New York, New York, United States of America; Department of Cardiovascular Diseases, Merck Research Laboratories, Rahway, New Jersey, United States of America; Department of Microbiology, New York University School of Medicine, New York, New York, United States of America; Center for Health Informatics and Bioinformatics, New York University School of Medicine, New York, New York, United States of America; Department of Medicine, Division of Translational Medicine, New York University School of Medicine, New York, New York, United States of America; Department of Pathology, New York University School of Medicine, New York, New York, United States of America; Informatics and Analysis, Merck Research Laboratories, Kenilworth, New Jersey, United States of America","Conceived and designed the experiments: JEF YV VR CW AS CFA MJG EAF OP. Performed the experiments: JEF YV VR CW AS CFA MJG EAF OP. Analyzed the data: JEF YV VR CW AS CFA MJG EAF OP. Wrote the paper: JEF YV VR CW AS CFA MJG EAF OP.","Vladimir Reiser and Oscar Puig worked for Merck at the time the research was carried out. Dr Garabedian has previously received research funds from Philip Morris USA, for research projects not related to the study reported in the manuscript. The remaining authors do not have any competing interests. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2012","06","Jonathan E Feig","JEF",9,TRUE,9,9,9,9,TRUE,TRUE,FALSE,0,NA,FALSE
